PHO-EARN

Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

Status:

OPEN TO ACCRUAL

Trial Type:

Endocrine Neuroendocrine, Genitourinary, Neurologic

Age Group:

Both

Phase:

II

NCT Number:

Contact:

DeNardo, Bradley

bdenardo@BrownHealth.org